Provided by Tiger Fintech (Singapore) Pte. Ltd.

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

21.47
-0.5300-2.41%
Post-market: 21.28-0.1900-0.88%17:58 EDT
Volume:528.31K
Turnover:11.47M
Market Cap:1.24B
PE:-8.29
High:22.29
Open:22.00
Low:21.38
Close:22.00
Loading ...

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

GlobeNewswire
·
30 May

Meet the New Group of Weight-Loss Drugs. The Industry Is Betting Big on Amylin. -- Barrons.com

Dow Jones
·
30 May

This biotech's stock rockets on oral obesity drug partnership with Wegovy parent

Dow Jones
·
14 May

Structure Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
12 May

Piper Sandler Reaffirms Their Buy Rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TIPRANKS
·
09 May

Structure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Structure Therapeutics Reports Q1 2025 Net Loss of $46.8 Million, Up from $26 Million in Q1 2024

Reuters
·
09 May

Structure Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
06 May

Structure Therapeutics initiated with a Buy at Citi

TIPRANKS
·
02 May

Is Structure Therapeutics Inc. (NASDAQ:GPCR) the Most Promising Small-Cap Stock According to Analysts?

Insider Monkey
·
26 Apr

LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study

Zacks
·
21 Apr

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

TipRanks
·
18 Apr

BUZZ-Eli Lilly jumps as pill leads to 7.9% weight loss in late-stage trial

Reuters
·
17 Apr

Shares of Obesity Drug Developer Structure Therapeutics up 24.6% Premarket After Eli Lilly's Pill Leads to 7.9% Weight Loss in Late-Stage Trial

THOMSON REUTERS
·
17 Apr

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

Zacks
·
15 Apr

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill

TIPRANKS
·
14 Apr

Viking, Structure rally after Pfizer halts obesity drug development

TIPRANKS
·
14 Apr

Obesity Drugmakers Shares Rise After Pfizer Ends Development of Weight-Loss Pill Danuglipron

Reuters
·
14 Apr

Press Release: Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results

Dow Jones
·
27 Mar

Biotech stocks have been hit by 'DOGE' and other fears. Why they're a great value now.

Dow Jones
·
27 Mar